课题基金 / 基金详情

GH13-002: MEASURING THE IMPACT OF ONCHOCERCIASIS CONTROL AND ELIMINATION PROBRA

GH13-002: MEASURING THE IMPACT OF ONCHOCERCIASIS CONTROL AND ELIMINATION PROBRA
GH13-002:衡量盘尾丝虫病控制和消除 Probra 的影响
批准号:
9128441
负责人:
SHEBA GITTA
金额:
$19.2万
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-08-01 至 2018-07-31

项目摘要

项目成果

SHEBA GITTA的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The proposed project has two objectives which will be implemented in three African countries (Uganda, DRC, and Ethiopia) which are endemic for onchocerciasis. The proposed project for Objective 1 will seek to measure the impact of onchocerciasis control and elimination programs. More specifically we seek to evaluate the evolution of biomarkers of onchocercial infection as mass drug administration (MDA) progresses, and to evaluate the performance of diagnostic tools for onchocercial infection in areas that are approaching the interruption of transmission. Recruitment of respondents into the study will be via convenience sampling. For Objective 1 we seek to recruit 1,500 participants, and for the second objective, 3000 participants, in conformance with the instructions in the request for proposals. Participants will be subjected to physical, oral and serologic examinations. Information generated from collected data will serve to inform policy makers so as to effectively promote and strengthen NTD elimination efforts. The project for Objective 2 seeks to measure the impact of onchocerciasis control and elimination programs using mass drug administration (MDA) on coendemic lymphatic filariasis (LF). More specifically the project seeks to develop a standardized protocol to evaluate the status of LF in the areas of onchocerciasis and LF overlap; evaluate the impact of mass drug administration of ivermectin for the control of onchocerciasis on reducing the prevalence and transmission of lymphatic filariasis (LF); and in LF implementation units (district), compare prevalence of LF between communities that have received ivermectin MDA with those that have not received it. Recruitment of respondents into the study will be via convenience sampling in the selected implementation units. Physical, oral and serologic and microscopic examinations will be performed on respondents. Information generated from collected data will serve to inform policy makers so as to effectively promote and strengthen NTD elimination efforts, with a possibility of calling for integration of onchocerciasis and LF.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
GH13-002: MEASURING THE IMPACT OF ONCHOCERCIASIS CONTROL AND ELIMINATION PROBRA
GH13-002: MEASURING THE IMPACT OF ONCHOCERCIASIS CONTROL AND ELIMINATION PROBRA
MEASURING THE IMPACT OF ONCHOCERCIASIS CONTROL AND ELIMINATION PROBRA
CONDUCTING PUBLIC HEALTH RESEARCH THROUGH FIELD EPIDEMIOLOGY AND LABORATORY TRAIN
国内基金
海外基金
锌粉(002)晶面定向调控及其负极性能强化机理研究
  • 批准号:
    2025JJ70625
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    曹鹏辉
  • 依托单位:
新型核素偶联药载体JBN002-DOTA的开发及其在肿瘤诊疗中的应用
  • 批准号:
    82373174
  • 项目类别:
    面上项目
  • 资助金额:
    60万元
  • 批准年份:
    2023
  • 负责人:
    杨杰
  • 依托单位:
tiRNA-Val-CAC-002介导ITGB3/PI3K/Akt调控FB自噬促进OSF发生机制研究
  • 批准号:
    2023JJ30946
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2023
  • 负责人:
    吴颖芳
  • 依托单位:
双胍新衍生物SMK-002阻断PKM2入核下调脂质合成抑制EMT阻止膀胱癌转移的作用和机制研究
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    55万元
  • 批准年份:
    2021
  • 负责人:
    杨小平
  • 依托单位: